{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T17:57:35Z","timestamp":1781459855700,"version":"3.54.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T00:00:00Z","timestamp":1757980800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences & Peking Union Medical College","doi-asserted-by":"publisher","award":["2021-I2M-1-043"],"award-info":[{"award-number":["2021-I2M-1-043"]}],"id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008871","name":"Yunnan Provincial Science and Technology Department","doi-asserted-by":"publisher","award":["202402AA310019"],"award-info":[{"award-number":["202402AA310019"]}],"id":[{"id":"10.13039\/501100008871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008871","name":"Yunnan Provincial Science and Technology Department","doi-asserted-by":"publisher","award":["202401AT070149"],"award-info":[{"award-number":["202401AT070149"]}],"id":[{"id":"10.13039\/501100008871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008990","name":"Science and Technology Department of Zhejiang Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008990","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFC2307900"],"award-info":[{"award-number":["2023YFC2307900"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunobiology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.imbio.2025.153121","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T04:17:15Z","timestamp":1759205835000},"page":"153121","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["A novel approach to poliovirus vaccine neurovirulence testing: development of an enhanced 4-level scoring system"],"prefix":"10.1016","volume":"230","author":[{"given":"Xi","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunguang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anguo","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changxu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bochuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingrun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yina","family":"Cun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.imbio.2025.153121_bb0005","doi-asserted-by":"crossref","first-page":"601","DOI":"10.3390\/vaccines8040601","article-title":"In-vitro inactivation of Sabin-polioviruses for development of safe and effective polio vaccine","volume":"8","author":"Abd-Elghaffar","year":"2020","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.imbio.2025.153121_bb0010","series-title":"Chinese Pharmacopoei: Volume III","author":"Chinese Pharmacopoeia Commission","year":"2025"},{"key":"10.1016\/j.imbio.2025.153121_bb0015","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1080\/14760584.2021.1919091","article-title":"Cross-neutralization capacity of immune serum from different dosage of Sabin inactivated poliovirus vaccine immunization against multiple individual polioviruses","volume":"20","author":"Chu","year":"2021","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.imbio.2025.153121_bb0020","article-title":"Is it time to switch to a formulation other than the live attenuated poliovirus vaccine to prevent poliomyelitis?","volume":"11","author":"Devaux","year":"2023","journal-title":"Front. Public Health"},{"key":"10.1016\/j.imbio.2025.153121_bb0025","series-title":"Neuroanatomy: An Illustrated Colour Text","author":"DSc ARCP, FRCP DNM","year":"2019"},{"key":"10.1016\/j.imbio.2025.153121_bb0030","series-title":"Neurologisch-topische diagnostik. Anatomie, physiologie, klinik. Stuttgart New York","author":"Duus","year":"1990"},{"key":"10.1016\/j.imbio.2025.153121_bb0035","doi-asserted-by":"crossref","first-page":"718","DOI":"10.3390\/vaccines12070718","article-title":"Detection of polioviruses type 2 among migrant children arriving to the Russian Federation from a country with a registered poliomyelitis outbreak","volume":"12","author":"Ivanova","year":"2024","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.imbio.2025.153121_bb0040","first-page":"328","article-title":"What is polio?","author":"K W, Pn M.","year":"2022","journal-title":"Jama"},{"key":"10.1016\/j.imbio.2025.153121_bb0045","doi-asserted-by":"crossref","first-page":"e917","DOI":"10.1016\/S2214-109X(23)00116-X","article-title":"Poliovirus antibodies following two rounds of campaigns with a type 2 novel oral poliovirus vaccine in Liberia: a clustered, population-based seroprevalence survey","volume":"11","author":"Kennedy","year":"2023","journal-title":"Lancet Glob. Health"},{"key":"10.1016\/j.imbio.2025.153121_bb0050","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2023.2173905","article-title":"Global trends in poliomyelitis research over the past 20 years: a bibliometric analysis","volume":"19","author":"Liu","year":"2023","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.imbio.2025.153121_bb0055","doi-asserted-by":"crossref","first-page":"e1213","DOI":"10.1016\/S2214-109X(25)00110-X","article-title":"Safety of nOPV2 administered during a supplementary immunisation activity in Uganda, 2022: Data triangulation from a prospective cohort event monitoring programme and vaccine safety surveillance reports","volume":"13","author":"Longley","year":"2025","journal-title":"Lancet Glob. Health"},{"key":"10.1016\/j.imbio.2025.153121_bb0060","doi-asserted-by":"crossref","first-page":"786","DOI":"10.15585\/mmwr.mm7124a2","article-title":"Genetic characterization of novel oral polio vaccine type 2 viruses during initial use phase under emergency use listing - worldwide, march-october 2021","volume":"71","author":"Martin","year":"2022","journal-title":"MMWR Morb. Mortal Wkly. Rep."},{"key":"10.1016\/j.imbio.2025.153121_bb0065","doi-asserted-by":"crossref","first-page":"710","DOI":"10.3390\/vaccines9070710","article-title":"Live viral vaccine neurovirulence screening: current and future models","volume":"9","author":"May Fulton","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.imbio.2025.153121_bb0070","doi-asserted-by":"crossref","first-page":"61","DOI":"10.5694\/mja2.50681","article-title":"The risks of medical complacency towards poliomyelitis","volume":"213","author":"May","year":"2020","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.imbio.2025.153121_bb0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010658","article-title":"Recombinant vesicular stomatitis vaccine against nipah virus has a favorable safety profile: Model for assessment of live vaccines with neurotropic potential","volume":"18","author":"Monath","year":"2022","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.imbio.2025.153121_bb0080","doi-asserted-by":"crossref","DOI":"10.15585\/mmwr.mm7341a1","article-title":"Update on vaccine-derived poliovirus outbreaks \u2014 worldwide, January 2023\u2013June 2024","volume":"73","author":"Namageyo-Funa","year":"2024","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.imbio.2025.153121_bb0085","doi-asserted-by":"crossref","first-page":"565","DOI":"10.3390\/vaccines9060565","article-title":"Immunogenicity and safety of inactivated Sabin-strain polio vaccine \u201cPoliovacSin\u201d: Clinical trials phase I and II","volume":"9","author":"Piniaeva","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.imbio.2025.153121_bb0090","unstructured":"Polio eradication strategy 2022\u20132026: Delivering on a promise n.d. https:\/\/www.who.int\/publications\/i\/item\/9789240031937 (accessed July 19, 2025)."},{"key":"10.1016\/j.imbio.2025.153121_bb0095","unstructured":"Recommendations to assure the quality, safety and efficacy of poliomyelitis vaccines (oral, live, attenuated), annex 2, TRS no 980 n.d. https:\/\/www.who.int\/publications\/m\/item\/oral-live-attenuated-poliomyelitis-vaccine-annex-2-trs-no-980 (accessed August 29, 2025)."},{"key":"10.1016\/j.imbio.2025.153121_bb0100","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.provac.2011.10.027","article-title":"Toward replacement of the monkey neurovirulence test in vaccine safety testing","volume":"5","author":"Rubin","year":"2011","journal-title":"Procedia Vaccinol."},{"key":"10.1016\/j.imbio.2025.153121_bb0105","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0140-6736(20)32540-X","article-title":"Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in children and infants: two clinical trials","volume":"397","author":"S\u00e1ez-Llorens","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.imbio.2025.153121_bb0110","doi-asserted-by":"crossref","first-page":"613","DOI":"10.15585\/mmwr.mm7223a1","article-title":"Surveillance to track progress toward poliomyelitis eradication - worldwide, 2021-2022","volume":"72","author":"Stehling-Ariza","year":"2023","journal-title":"MMWR Morb. Mortal Wkly. Rep."},{"key":"10.1016\/j.imbio.2025.153121_bb0115","article-title":"Immuno-persistence of the different primary polio vaccine schedules and immunogenicity of the booster dose by Sabin inactivated or bivalent oral poliovirus vaccine in children aged 4 years: an open-label, randomised, controlled phase 4 trial in China","volume":"34","author":"Tang","year":"2023","journal-title":"Lancet Reg. Health West Pac."},{"key":"10.1016\/j.imbio.2025.153121_bb0120","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.chom.2020.10.011","article-title":"The early evolution of oral poliovirus vaccine is shaped by strong positive selection and tight transmission bottlenecks","volume":"29","author":"Valesano","year":"2021","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.imbio.2025.153121_bb0125","doi-asserted-by":"crossref","first-page":"e912","DOI":"10.1016\/S2666-5247(22)00254-3","article-title":"Genetic and phenotypic stability of poliovirus shed from infants who received novel type 2 or Sabin type 2 oral poliovirus vaccines in Panama: an analysis of two clinical trials","volume":"3","author":"Wahid","year":"2022","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.imbio.2025.153121_bb0130","first-page":"28","article-title":"Comparative study on MNVT of OPV type I and III reference products in different periods","volume":"11","author":"Wang","year":"2023","journal-title":"Diseases (Basel, Switzerland)"},{"key":"10.1016\/j.imbio.2025.153121_bb0135","article-title":"Immunogenicity of two-dose and three-dose vaccination schedules with Sabin inactivated poliovirus vaccine in China: an open-label, randomized, controlled trial","volume":"10","author":"Wang","year":"2021","journal-title":"Lancet Reg. Health West Pac."},{"key":"10.1016\/j.imbio.2025.153121_bb0140","unstructured":"WHO-Neurovirulence test of types 1, 2 or 3 live attenuated poliomyelitis vaccines (oral) in monkeys n.d. https:\/\/www.who.int\/publications\/m\/item\/neurovirulence-test-of-types-1-2-or-3-opv-in-monkeys (accessed June 5, 2024)."},{"key":"10.1016\/j.imbio.2025.153121_bb0145","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/S1473-3099(23)00139-1","article-title":"Immunogenicity of novel oral poliovirus vaccine type 2 administered concomitantly with bivalent oral poliovirus vaccine: an open-label, non-inferiority, randomised, controlled trial","volume":"23","author":"Wilkinson","year":"2023","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.imbio.2025.153121_bb0150","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.15585\/mmwr.mm7136a2","article-title":"Detection of a highly divergent type 3 vaccine-derived poliovirus in a child with a severe primary immunodeficiency disorder - Chongqing, China, 2022","volume":"71","author":"Yao","year":"2022","journal-title":"MMWR Morb. Mortal Wkly. Rep."},{"key":"10.1016\/j.imbio.2025.153121_bb0155","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/s41586-023-06212-3","article-title":"Genetic stabilization of attenuated oral vaccines against poliovirus types 1 and 3","volume":"619","author":"Yeh","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.imbio.2025.153121_bb0160","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0140-6736(22)02397-2","article-title":"Evaluation of the safety, immunogenicity, and faecal shedding of novel oral polio vaccine type 2 in healthy newborn infants in Bangladesh: a randomised, controlled, phase 2 clinical trial","volume":"401","author":"Zaman","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.imbio.2025.153121_bb0165","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/s41541-024-00831-1","article-title":"Immune persistence after different polio sequential immunization schedules in Chinese infants","volume":"9","author":"Zhao","year":"2024","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.imbio.2025.153121_bb0170","first-page":"5","article-title":"Environmental surveillance of a circulating vaccine-derived poliovirus type 2 outbreak in Israel between 2022 and 2023: a genomic epidemiology study. The Lancet","author":"Zuckerman","year":"2024","journal-title":"Microbe"}],"container-title":["Immunobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298525002554?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298525002554?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T17:12:11Z","timestamp":1781457131000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0171298525002554"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S0171298525002554"],"URL":"https:\/\/doi.org\/10.1016\/j.imbio.2025.153121","relation":{},"ISSN":["0171-2985"],"issn-type":[{"value":"0171-2985","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel approach to poliovirus vaccine neurovirulence testing: development of an enhanced 4-level scoring system","name":"articletitle","label":"Article Title"},{"value":"Immunobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imbio.2025.153121","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"153121"}}